Combination of solifenacin and mirabegron for overactive bladder management

E-ISSN： 1464-410x|116|4|498-499

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.4, 2015-10, pp. : 498-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solifenacin for the treatment of overactive bladder

By Robinson Dudley Cardozo Linda

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite

Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study

Urologia Internationalis, Vol. 97, Iss. 3, 2016-04 ,pp. : 325-329

Karger

Access to resources Recommend Favorite

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent developments in the management of overactive bladder: focus on the efficacy and tolerability of once daily solifenacin succinate 5 mg

By Brunton Stephen Kuritzky Louis

Current Medical Research and Opinion, Vol. 21, Iss. 1, 2005-01 ,pp. : 71-80

Informa Healthcare

Access to resources Recommend Favorite

The Role of Mirabegron in Overactive Bladder: A Systematic Review and Meta-Analysis

Urologia Internationalis, Vol. 93, Iss. 3, 2014-08 ,pp. : 326-337

Karger

Access to resources Recommend Favorite